These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 15206590)
21. Zinc-carnosine and vitamin E supplementation does not ameliorate gastrointestinal side effects associated with ciclosporin therapy of canine atopic dermatitis. Wilson LS; Rosenkrantz WS; Roycroft LM Vet Dermatol; 2011 Feb; 22(1):53-60. PubMed ID: 20586994 [TBL] [Abstract][Full Text] [Related]
22. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis. Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915 [TBL] [Abstract][Full Text] [Related]
23. Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis. Bäumer W; Stahl J; Sander K; Petersen LJ; Paps J; Stark H; Kietzmann M; Olivry T Exp Dermatol; 2011 Jul; 20(7):577-81. PubMed ID: 21521369 [TBL] [Abstract][Full Text] [Related]
24. Safety of levocetirizine treatment in young atopic children: An 18-month study. Simons FE; Pediatr Allergy Immunol; 2007 Sep; 18(6):535-42. PubMed ID: 17561929 [TBL] [Abstract][Full Text] [Related]
25. The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial. Marsella R; Nicklin CF; Melloy C Vet Dermatol; 2002 Jun; 13(3):131-9. PubMed ID: 12074702 [TBL] [Abstract][Full Text] [Related]
26. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs. Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study. Bensignor E; Morgan DM; Nuttall T Vet Dermatol; 2008 Jun; 19(3):156-62. PubMed ID: 18477332 [TBL] [Abstract][Full Text] [Related]
28. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891 [TBL] [Abstract][Full Text] [Related]
29. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Fontaine J; Olivry T Vet Rec; 2001 May; 148(21):662-3. PubMed ID: 11400987 [No Abstract] [Full Text] [Related]
30. Review of cetirizine hydrochloride for the treatment of allergic disorders. Portnoy JM; Dinakar C Expert Opin Pharmacother; 2004 Jan; 5(1):125-35. PubMed ID: 14680442 [TBL] [Abstract][Full Text] [Related]
31. Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis. Ohshima-Terada Y; Higuchi Y; Kumagai T; Hagihara A; Nagata M Vet Dermatol; 2015 Oct; 26(5):350-3, e74-5. PubMed ID: 26123498 [TBL] [Abstract][Full Text] [Related]
32. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Steffan J; Parks C; Seewald W; J Am Vet Med Assoc; 2005 Jun; 226(11):1855-63. PubMed ID: 15934253 [TBL] [Abstract][Full Text] [Related]
33. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Diepgen TL; Pediatr Allergy Immunol; 2002 Aug; 13(4):278-86. PubMed ID: 12390444 [TBL] [Abstract][Full Text] [Related]
34. [Antihistaminics. Side effects also after raising dosage at the placebo level]. MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280 [No Abstract] [Full Text] [Related]
35. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975 [TBL] [Abstract][Full Text] [Related]
37. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus. Tamamoto-Mochizuki C; Murphy KM; Olivry T Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176 [TBL] [Abstract][Full Text] [Related]
38. Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis. Yamanaka K; Motomura E; Noro Y; Umeda K; Morikawa T; Umeda-Togami K; Omoto Y; Isoda K; Kondo M; Tsuda K; Okuda M; Gabazza EC; Mizutani H Exp Dermatol; 2015 Mar; 24(3):227-9. PubMed ID: 25641045 [TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy of low-level laser therapy on localized canine atopic dermatitis severity score and localized pruritic visual analog score in pedal pruritus due to canine atopic dermatitis. Stich AN; Rosenkrantz WS; Griffin CE Vet Dermatol; 2014 Oct; 25(5):464-e74. PubMed ID: 24909192 [TBL] [Abstract][Full Text] [Related]
40. Nonsteroidal, nonimmunosuppressive therapies for pruritus. Bloom P Vet Clin North Am Small Anim Pract; 2013 Jan; 43(1):173-87. PubMed ID: 23182331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]